Ticagrelor, but not clopidogrel, attenuated hepatic steatosis in a model of non-alcoholic fatty liver disease

被引:0
|
作者
Oh, Hyunwoo [1 ]
Lee, Hyo Young [1 ]
Park, Huiyul [2 ]
Jun, Dae Won [3 ]
Yoon, Eileen [3 ]
Ahn, Sang Bong [4 ]
Lee, Chul-min [5 ]
Kim, Mi Mi [5 ]
Kang, Bo-Kyeong [5 ]
Sohn, Joo Hyun [6 ]
机构
[1] Uijeongbu Eulji Med Ctr, Dept Med, Uijeongbu Si, Gyeonggi do, South Korea
[2] Uijeongbu Eulji Med Ctr, Dept Family med, Uijeongbu Si, Gyeonggi do, South Korea
[3] Hanyang Univ, Coll Med, Dept Med, Seoul, South Korea
[4] Eulji Univ, Nowon Eulji Med Ctr, Sch Med, Dept Med, Seoul, South Korea
[5] Hanyang Univ, Coll Med, Dept Radiol, Seoul, South Korea
[6] Hanyang Univ, Guri Hosp, Coll Med, Dept Med, Ansan, Gyeonggi do, South Korea
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
SAT135
引用
收藏
页码:S728 / S729
页数:2
相关论文
共 50 条
  • [21] NON-ALCOHOLIC STEATOSIS HEPATITIS AND FATTY CIRRHOSIS MIMICKING ALCOHOLIC LIVER-DISEASE
    SPECH, HJ
    LIEHR, H
    MITSCHKE, H
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 1983, 21 (11): : 651 - 659
  • [22] Risk factors for hepatic steatosis in adults with cystic fibrosis: Similarities to non-alcoholic fatty liver disease
    Fares Ayoub
    Cesar Trillo-Alvarez
    Giuseppe Morelli
    Jorge Lascano
    World Journal of Hepatology, 2018, 10 (01) : 34 - 40
  • [23] Exercise as a treatment strategy for non-alcoholic fatty liver disease: impact on vascular health and hepatic steatosis
    Pugh, C. J. A.
    Jones, H.
    Sprung, V. S.
    Kemp, G. J.
    Irwin, A.
    Adams, V. L.
    Green, D. J.
    Cable, N. T.
    Richardson, P.
    Umpleby, A. M.
    Cuthbertson, D. J.
    DIABETOLOGIA, 2011, 54 : S247 - S247
  • [24] Inhibiting Ceramide Synthesis Attenuates Hepatic Steatosis and Fibrosis in Rats With Non-alcoholic Fatty Liver Disease
    Jiang, Meng
    Li, Chun
    Liu, Qiaoshu
    Wang, Aimin
    Lei, Minxiang
    FRONTIERS IN ENDOCRINOLOGY, 2019, 10
  • [25] Relationship Between Non-Alcoholic Fatty Liver Disease and Degree of Hepatic Steatosis and Bone Mineral Density
    Xie, Ruijie
    Liu, Mingjiang
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [26] Risk factors for hepatic steatosis in adults with cystic fibrosis: Similarities to non-alcoholic fatty liver disease
    Ayoub, Fares
    Trillo-Alvarez, Cesar
    Morelli, Giuseppe
    Lascano, Jorge
    WORLD JOURNAL OF HEPATOLOGY, 2018, 10 (01) : 34 - 40
  • [27] The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease
    Ryan, Marno C.
    Itsiopoulos, Catherine
    Thodis, Tania
    Ward, Glenn
    Trost, Nicholas
    Hofferberth, Sophie
    O'Dea, Kerin
    Desmond, Paul V.
    Johnson, Nathan A.
    Wilson, Andrew M.
    JOURNAL OF HEPATOLOGY, 2013, 59 (01) : 138 - 143
  • [28] Effect of severity of steatosis as assessed ultrasonographically on hepatic vascular indices in non-alcoholic fatty liver disease
    Mohammadi, Afshin
    Ghasemi-rad, Mohammad
    Zahedi, Hengameh
    Toldi, Gergely
    Alinia, Tahereh
    MEDICAL ULTRASONOGRAPHY, 2011, 13 (03) : 200 - 206
  • [29] Hepatic lipid metabolism and non-alcoholic fatty liver disease
    Tessari, P.
    Coracina, A.
    Cosma, A.
    Tiengo, A.
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2009, 19 (04) : 291 - 302
  • [30] Hepatic Chemerin is Induced in Non-Alcoholic Fatty Liver Disease
    Buechler, Christa
    Wanninger, Josef
    Bauer, Sabrina
    Eisinger, Kristina
    Schacherer, Doris
    Hellerbrand, Claus
    Weiss, Thomas S.
    Schaffler, Andreas
    DIABETES, 2012, 61 : A691 - A692